Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study

Cancer Treat Rep. 1986 Oct;70(10):1247-8.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / mortality
  • Aged
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use*
  • Brain Diseases / chemically induced
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Clinical Trials as Topic
  • Drug Evaluation
  • Female
  • Hematologic Diseases / chemically induced
  • Humans
  • Isoxazoles / adverse effects
  • Isoxazoles / therapeutic use*
  • Middle Aged
  • Neoplasm Metastasis
  • Oxazoles / therapeutic use*

Substances

  • Antibiotics, Antineoplastic
  • Isoxazoles
  • Oxazoles
  • acivicin